Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Durogesic in Pediatric Chronic Pain
NCT00271453Phase 3Completed
- Sponsor
- Johnson & Johnson
- Start
- Feb 1996
- Modality
- Orthosteric Ligands
01
Overview
Phase 3, open-label, single-arm trial of fentanyl in chronic pain, sponsored by Johnson & Johnson. Primary endpoints: Patient assessment of treatment at Day 15, Pain level assessed by patient or parent at Day 15 and 1 more. Started Feb 1996; status: completed.
02
Drugs
fentanyl
03
Conditions
chronic pain
Beyond the preview
Go deeper on NCT00271453.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00271453.